Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Leukemic Stem Cells: A ReviewO'Brien, J. A. ; Rizzieri, D. A.Cancer investigation, 2013-05, Vol.31 (4), p.215-220 [Periódico revisado por pares]New York, NY: Informa HealthcareTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)Kantarjian, Hagop M. ; Begna, Kebede H. ; Altman, Jessica K. ; Goldberg, Stuart L. ; Sekeres, Mikkael A. ; Strickland, Stephen A. ; Arellano, Martha L. ; Claxton, David F. ; Baer, Maria R. ; Gautier, Marc ; Berman, Ellin ; Seiter, Karen ; Solomon, Scott R. ; Schiller, Gary J. ; Luger, Selina M. ; Butrym, Aleksandra ; Gaidano, Gianluca ; Thomas, Xavier G. ; Montesinos, Pau ; Rizzieri, David A. ; Quick, Donald P. ; Venugopal, Parameswaran ; Gaur, Rakesh ; Maness, Lori J. ; Kadia, Tapan M. ; Ravandi, Farhad ; Buyse, Marc E. ; Chiao, Judy H.Cancer, 2021-12, Vol.127 (23), p.4421-4431 [Periódico revisado por pares]United States: Wiley Subscription Services, IncTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cellsJORDAN, C. T ; UPCHURCH, D ; LUGER, S. M ; PHILLIPS, G. L ; SZILVASSY, S. J ; GUZMAN, M. L ; HOWARD, D. S ; PETTIGREW, A. L ; MEYERROSE, T ; ROSSI, R ; GRIMES, B ; RIZZIERI, D. ALeukemia, 2000-10, Vol.14 (10), p.1777-1784 [Periódico revisado por pares]London: Nature PublishingTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemiaGiles, F J ; Swords, R T ; Nagler, A ; Hochhaus, A ; Ottmann, O G ; Rizzieri, D A ; Talpaz, M ; Clark, J ; Watson, P ; Xiao, A ; Zhao, B ; Bergstrom, D ; Le Coutre, P D ; Freedman, S J ; Cortes, J ELeukemia, 2013-01, Vol.27 (1), p.113-117 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemiaBorthakur, Gautam ; Odenike, Olatoyosi ; Aldoss, Ibrahim ; Rizzieri, David A. ; Prebet, Thomas ; Chen, Chris ; Popovic, Relja ; Modi, Dimple A. ; Joshi, Rujuta H. ; Wolff, Johannes E. ; Jonas, Brian A.Cancer, 2021-08, Vol.127 (16), p.2943-2953 [Periódico revisado por pares]United States: Wiley Subscription Services, IncTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trialKantarjian, Hagop M ; Roboz, Gail J ; Kropf, Patricia L ; Yee, Karen W L ; O'Connell, Casey L ; Tibes, Raoul ; Walsh, Katherine J ; Podoltsev, Nikolai A ; Griffiths, Elizabeth A ; Jabbour, Elias ; Garcia-Manero, Guillermo ; Rizzieri, David ; Stock, Wendy ; Savona, Michael R ; Rosenblat, Todd L ; Berdeja, Jesus G ; Ravandi, Farhad ; Rock, Edwin P ; Hao, Yong ; Azab, Mohammad ; Issa, Jean-Pierre JThe lancet oncology, 2017-10, Vol.18 (10), p.1317-1326 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysisMichelis, Fotios V. ; Gupta, Vikas ; Zhang, Mei‐Jie ; Wang, Hai‐Lin ; Aljurf, Mahmoud ; Bacher, Ulrike ; Beitinjaneh, Amer ; Chen, Yi‐Bin ; DeFilipp, Zachariah ; Gale, Robert Peter ; Kebriaei, Partow ; Kharfan‐Dabaja, Mohamed ; Lazarus, Hillard M. ; Nishihori, Taiga ; Olsson, Richard F. ; Oran, Betul ; Rashidi, Armin ; Rizzieri, David A. ; Tallman, Martin S. ; de Lima, Marcos ; Khoury, H. Jean ; Sandmaier, Brenda M. ; Weisdorf, Daniel ; Saber, WaelCancer, 2017-06, Vol.123 (11), p.2035-2042 [Periódico revisado por pares]United States: Wiley Subscription Services, IncTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemiaRoboz, Gail J. ; Kantarjian, Hagop M. ; Yee, Karen W. L. ; Kropf, Patricia L. ; O'Connell, Casey L. ; Griffiths, Elizabeth A. ; Stock, Wendy ; Daver, Naval G. ; Jabbour, Elias ; Ritchie, Ellen K. ; Walsh, Katherine J. ; Rizzieri, David ; Lunin, Scott D. ; Curio, Tania ; Chung, Woonbok ; Hao, Yong ; Lowder, James N. ; Azab, Mohammad ; Issa, Jean‐Pierre J.Cancer, 2018-01, Vol.124 (2), p.325-334 [Periódico revisado por pares]United States: Wiley Subscription Services, IncTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTRWieduwilt, Matthew J ; Stock, Wendy ; Advani, Anjali ; Luger, Selina ; Larson, Richard A ; Tallman, Martin ; Appelbaum, Frederick ; Zhang, Mei-Jie ; Bo-Subait, Khalid ; Wang, Hai-Lin ; Bhatt, Vijaya Raj ; Dholaria, Bhagirathbhai ; Eapen, Mary ; Hamadani, Mehdi ; Jamy, Omer ; Prestidge, Tim ; Pulsipher, Michael ; Ritchie, David ; Rizzieri, David ; Sharma, Akshay ; Barba, Pere ; Sandmaier, Brenda M ; de Lima, Marcos ; Kebriaei, Partow ; Litzow, Mark ; Saber, Wael ; Weisdorf, DanielLeukemia, 2021-07, Vol.35 (7), p.2076-2085 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemiaWEINBERG, J. B ; VOLKHEIMER, A. D ; RIZZIERI, D. A ; LEVESQUE, M. C ; DEKROON, R ; STRITTMATTER, W. J ; MIHOVILOVIC, M ; JIANG, N ; CHEN, Y ; BOND, K ; MOORE, J. O ; GOCKERMAN, J. P ; DIEHL, L. F ; DE CASTRO, C. MLeukemia, 2008-12, Vol.22 (12), p.2184-2192 [Periódico revisado por pares]Avenel, NJ: Nature Publishing GroupTexto completo disponível |